NURPF Stock Overview – The Average Joe
Business Economy Tech Subscribe About Us
PNK:NURPF

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

July 29, 2024

Description

Loading...

Price Performance

1M 6M 1Y 5Y 10Y
$NURPF N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A

Valuation

P/E Ratio (TTM) P/S Ratio (TTM)
Neuren Pharmaceuticals Limited Loading... Loading...
Sector Name Loading... N/A

Related

MOLNMolecular Partners AG3.0%
MNOVMediciNova, Inc.-3.5%
ANEBAnebulo Pharmaceuticals, Inc.-0.9%
CSBRChampions Oncology, Inc.1.3%
CYTCyteir Therapeutics, Inc.-2.3%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue0M0M0M0M14M0M1M3M15M232M
Growth Rate-0.0%0.0%0.0%0.0%-96.3%44.8%345.9%355.2%1,493.7%
EBITDA-13M-17M-15M-6M5M-12M-10M-11M-2M199M
EBITDA Margin0.0%0.0%0.0%0.0%39.6%-2,337.6%-1,328.6%-357.5%-11.0%85.9%
Net Income-8M-13M-12M-2M3M-11M-9M-8M0M157M
NI Margin0.0%0.0%0.0%0.0%22.7%-2,185.1%-1,282.1%-243.8%1.3%67.7%